CVM (CVM) Stock Price & Analysis
CVM (CVM) rose 6.13% to USD 1.73 as of September 8, 2026 at 18:32 UTC, according to Nexqual real-time market data.
CVM last closed at USD 1.73; the session ranged USD 1.64–1.77 on volume of 249,618 shares. Market capitalization is —, with a 52-week range of USD 0.89–10.83 (ASE). Source: Nexqual, September 8, 2026 at 18:32 UTC.
Key Statistics (as of September 8, 2026 at 18:32 UTC)
| Price | USD 1.73 |
|---|---|
| Change | ▲ 6.13% (up) |
| Previous Close | USD 1.73 |
| Open | USD 1.73 |
| Day Range | USD 1.64 – 1.77 |
| 52-Week Range | USD 0.89 – 10.83 |
| Volume | 249,618 shares |
| Market Cap | — |
| Exchange | ASE |
Technical Analysis (CVM)
Nexqual's technical model rates CVM "BUY" based on 5 bullish and 2 bearish signals across 127 daily candles, as of September 8, 2026 at 18:32 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 64.8 (neutral) |
| vs SMA50 | Above (USD 1.38) |
| MACD | 0.07 (positive) |
From CVM's Latest SEC 10-K Filing (filed 2025-12-29)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| AGEN | Agenus Inc. | USD 7.71 | ▼ 6.43% |
| BGMSP | Bio Green Med Solution Inc. | USD 2.81 | ▲ 0% |
| CRIS | Curis, Inc. | USD 1.27 | ▼ 7.66% |
| BCRX | BioCryst Pharmaceuticals, Inc. | USD 9.18 | ▼ 9.07% |
| CASIF | CASI Pharmaceuticals, Inc. | USD 0.14 | ▼ 6.67% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: September 8, 2026 at 18:32 UTC. This page is informational and not investment advice.